News

Further STEMI progress requires new focus

Publish date: January 24, 2013

 

EXPERT OPINION FROM THE ANNUAL CARDIOVASCULAR CONFERENCE AT SNOWMASS

Dr. Gersh reported that he serves as a consultant to Abbott, Boston Scientific, GE Healthcare, and other companies.

b.jancin@elsevier.com

Pages

Recommended Reading

Chelation Trial: Results Positive but Not Practice Changing
MDedge Family Medicine
Fine-Tuning Therapeutic Hypothermia After Cardiac Arrest
MDedge Family Medicine
Troponin Guidelines Sort Out When to Order, How to Read
MDedge Family Medicine
Survival After In-Hospital Cardiac Arrest Has Improved Substantially
MDedge Family Medicine
Pregnancy Loss Boosts Multiple Atherosclerotic Risks
MDedge Family Medicine
Guidelines Update Approaches to Stable Ischemic Heart Disease
MDedge Family Medicine
Prasugrel's use grows, but often off label
MDedge Family Medicine
ED syncope observation protocol safely saves money
MDedge Family Medicine
Hospital readmissions under attack
MDedge Family Medicine
Stopping aspirin after bleeding ulcer raises CV death rate sixfold
MDedge Family Medicine